New Strategies for Improving the Quality of Life of Cancer Survivors: Reversible p53 Inhibition
- *Corresponding Author:
- Jing Wang
INSERM-UMR 1051, Institut des
Neurosciences de Montpellier
34295 Montpellier, France
Tel: 33499 636 048
Fax: 33499 636 020
E-mail: [email protected]
Received Date: May 31, 2017 Accepted Date: June 23, 2017 Published Date: June 26, 2017
Citation: Benkafadar N, Coyat C, Lloyd R, Jean-Luc P, Wang J (2017) New Strategies for Improving the Quality of Life of Cancer Survivors: Reversible p53 Inhibition. J Cancer Sci Ther 9: 490-491. doi: 10.4172/1948-5956.1000464
Copyright: © 2017 Benkafadar N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In recent years, with the improvement of cancer survival through more effective treatment, the emphasis has been in trying to minimize the side-effects caused by chemo- and radiotherapy, to ensure that patients have the best quality of life throughout their cancer journey. The tumor suppressor p53 is widely implicated in a broad range of cancers, and here we summarize its role and the possibilities of its manipulation to improve side effects during active treatment through survivorship.